High PLR (n=150) | Low PLR (n=295) | P value | |
Number of diseased vessels | |||
1, n (%) | 54 (36) | 103 (35) | 0.821 |
≥2, n (%) | 96 (64) | 192 (65) | |
Number of stent use | |||
1, n (%) | 66 (44) | 119 (40) | 0.459 |
≥2, n (%) | 84 (56) | 176 (60) | |
Stent length, average (mm, x±s) | 26.4±8.1 | 25.9±6.3 | 0.067 |
Stent diameter, average (mm, x±s) | 2.93±0.47 | 2.96±0.40 | 0.015 |
Tirofiban use, n (%) | 135 (90) | 271 (92) | 0.511 |
Thrombus aspiration, n (%) | 96 (64) | 153 (52) | 0.015 |
Postprocedural TIMI grade | |||
0–2, n (%) | 25 (17) | 29 (10) | 0.037 |
3, n (%) | 125 (83) | 266 (90) | |
MBG grade | |||
0 and 1, n (%) | 16 (11) | 12 (4) | 0.007 |
2 and 3, n (%) | 134 (89) | 283 (96) | |
Insufficient myocardial reperfusion, n (%) | 35 (23) | 37 (13) | 0.003 |
MBG, myocardial blush grade; PLR, platelet-to-lymphocyte ratio; TIMI, thrombolysis in myocardial infarction.